Researchers from seven Environment for Development (EfD) centers plus the EfD Global Hub, located at the University of Gothenburg, have conducted an extensive survey on how serious people perceive COVID-19.
Jan 26, 2024
0
20
On January 3, 2024, Mikhail V. Blagosklonny M.D., Ph.D., from Roswell Park Comprehensive Cancer Center published a new brief report in Oncoscience titled "My battle with cancer. Part 1."
Jan 22, 2024
0
0
Researchers have identified a receptor protein known as CHRM1 as a key player in prostate cancer cells' resistance to docetaxel, a commonly-used chemotherapy drug to treat advanced cancer that has spread beyond the prostate.
Jan 22, 2024
0
15
Before a drug can be used to treat a disease, it must go through a lengthy and expensive trial process to prove both safety and effectiveness. By repurposing already-approved drugs, researchers can cut out the time and expense ...
Jan 12, 2024
0
12
A new Cleveland Clinic study shows there are disparities in cancer research and advocacy funding and that less funding strongly correlates with fewer clinical trials in a particular disease.
Jan 9, 2024
0
0
Lung cancer accounts for nearly 20% of annual cancer-related deaths worldwide. According to 2022 statistics from the Swiss Cancer League, nearly 5,000 new cases of lung cancer are reported in Switzerland each year. Over the ...
Jan 8, 2024
0
0
Research published in Journal of Shanghai Jiao Tong University (Science) has proposed a new method for lung image registration named Dlung. Dlung is an unsupervised few-shot learning-based diffeomorphic lung image registration, ...
Jan 7, 2024
0
6
A phase III LIBRETTO-431 multicenter study has evaluated the efficacy and safety of selpercatinib compared to control treatment, which consisted of platinum-based chemotherapy associated or not with pembrolizumab (immune ...
Jan 5, 2024
0
1
Immune checkpoint inhibitors (ICIs) are used to treat a variety of different cancers. ICIs are antibodies that sensitize the body's own immune system to detect and destroy tumors. However, ICIs are not effective in all patients, ...
Jan 3, 2024
0
50
A study of more than 9,000 persons screened for lung cancer found that rates of downstream procedures and complications associated with screening are substantially higher in routine clinical practice than previously observed ...
Jan 1, 2024
0
0
